A detailed history of Cyr Financial Inc. transactions in Eli Lilly & CO stock. As of the latest transaction made, Cyr Financial Inc. holds 730 shares of LLY stock, worth $591,613. This represents 0.51% of its overall portfolio holdings.

Number of Shares
730
Holding current value
$591,613
% of portfolio
0.51%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Jan 23, 2025

BUY
$727.2 - $932.06 $530,856 - $680,403
730 New
730 $564 Million

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $770B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Cyr Financial Inc. Portfolio

Follow Cyr Financial Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cyr Financial Inc., based on Form 13F filings with the SEC.

News

Stay updated on Cyr Financial Inc. with notifications on news.